WEDNESDAY, MAY 28, 2008

09:00-10:50

SESSION I: EARLY PHASES: PHASE I AND SAFETY
Chairperson: Dr. Kobi Atsmon,
Tel Aviv Sourasky Medical Center, Israel

Dan Panorama – Golan Hall

09:00-09:10

WELCOME AND INTRODUCTORY REMARKS 

09:10-09:35

Early Phase Studies - The Israeli Perspective
Dr. Kobi Atsmon
Tel Aviv Sourasky Medical Center, Israel

09:35-10:00

Preclinical Testing Elements Towards Clinical Trials
Dr. Yona Grunfeld
Harlan Biotech, Israel

10:00-10:25

Phase I Studies- Current Thoughts
Dr. Hedva Voliovitch
Teva Pharmaceutical Industries, Israel

10:25-10:50

Bioethical Aspects of Early Phase Trials in Humans
Dr. Avshalom Adam
The MBA Program, The College of Management, Israel

10:50-11:20

COFFEE BREAK

11:20-13:00

SESSION II: E-CLINICAL TRIALS: TECHNOLOGIES AND REGULATIONS
Chairperson: Tali Azulay,
BioForum CDmC, Israel

Dan Panorama - Golan Hall

11:20-11:40

The Changing Face of Clinical Data Management
Tali Azulay
BioForum CDmC, Israel

11:40-12:20

Validation and Regulatory Compliance of eSystems for Conducting Global Clinical Trials; Providing Insight and Recommendations for Compliant Implementation of EDC in the eSystem Clinical Environment
Michael Owings
Phase Forward, USA

12:20-13:00

How Much Do Electronic Diaries Improve the Quality of Clinical Trials Data?
Dr. Valdo Arnera
PHT Corporation, Switzerland

13:00-14:00

LUNCH BREAK

14:00-17:00

SESSION III: CLINICAL TRIALS: THE BRIDGE FROM FICTION TO REALITY
Chairperson: Dr. Julian Itzcovitz, Venture Technologies, Israel

Dan Panorama - Golan Hall

14:00-14:30

Magnetic Resonance-Guided laser Interstitial Thermal Treatment of Resistant Metastatic Brain Tumors
Dr. Julian Itzcovitz
Venture Technologies, France

14:30-15:00

New Directions in Brain Imaging Research & Applications
Dr. Dafna Ben Bashat
Tel Aviv Sourasky Medical Center, Israel

15:00-16:00

COFFEE BREAK

16:00-16:30

Convection-Enhanced Drug Delivery
Dr. Yael Mardor
Sheba Medical Center, Israel

16:30-17:00

Vascular Targeted Photodynamic Therapy (VTP) of Localized Prostate Cancer-From the Lab to the Clinic
Prof. Avigdor Scherz
The Weizmann Institute of Science, Israel